Hematologic Cancers

Bridging Therapy Prior to CAR-T Is Not Recommended for All Patients With Lymphoma

By

Bryant Furlow

Publish Date December 11, 2019

Researchers noted that bridging while awaiting CAR-T manufacturing may not be appropriate for all patients, and in some cases, bridging was associated with worse PFS and OS.

Many Young Adult Hematopoietic Cell Transplant Survivors May Need Return-to-Work Interventions Post Transplant

By

Tiffany Garbutt, PhD

Publish Date December 10, 2019

Data from the CIBMTR demonstrate a need to develop return-to-work interventions for patients who have undergone HCT as treatment of malignant, as well as nonmalignant, conditions.

Assessing VTE Risk Based on Presence of Elevated Biomarkers Provides Better Risk Stratification Than Current Methods

By

Tiffany Garbutt, PhD

Publish Date December 9, 2019

New scoring method provides a more nuanced risk stratification of VTE than the Khorana score in ambulatory patients with cancer.

Use of Billed Palliative Care Services by Patients With Hematologic Malignancies Mostly Related to EOL Care

By

Vicki Moore, PhD

Publish Date December 8, 2019

A review of SEER – Medicare database revealed increasing use of billed palliative care services; however, its use is still more closely related to end-of-life care.

Patients, Caregivers Experience Different Quality of Life, Burdens Following Outpatient Autologous Stem Cell Transplantation

By

Vicki Moore, PhD

Publish Date December 7, 2019

Researchers sought to determine the opportunity costs for patients and caregivers in the inpatient vs outpatient settings for patients undergoing ASCT.